Evidence for a relationship between VEGF and BMI independent of insulin sensitivity by glucose clamp procedure in a homogenous group healthy young men

PLoS ONE

Volumn 5, Issue 9, 2010, Pages 1-5

  Loebig, Michaela ^a   Klement, Johanna ^a   Schmoller, André ^a   Betz, Simone ^a   Heuck, Nicole ^a   Schweiger, Ulrich ^a   Peters, Achim ^a   Schultes, Bernd ^b   Oltmanns, Kerstin M ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

^b CANTONAL HOSPITAL ST GALLEN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; CATECHOLAMINE; CORTICOTROPIN; GLUCOSE; HYDROCORTISONE; INSULIN; NORADRENALIN; VASCULOTROPIN; VASCULOTROPIN A;

ADULT; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; GOLD STANDARD; HUMAN; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; MALE; OBESITY; ADOLESCENT; BLOOD; HEALTH STATUS; METABOLISM;

ADOLESCENT; ADULT; BODY MASS INDEX; BODY WEIGHT; CATECHOLAMINES; GLUCOSE CLAMP TECHNIQUE; HEALTH STATUS; HUMANS; HYDROCORTISONE; INSULIN; MALE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; YOUNG ADULT;

EID: 77958523798     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0012610     Document Type: Article

References (32)

1. Ferrara N (2004) Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev 25: 581-611.
2. Bates DO, Hillman NJ, Williams B, Neal CR, Pocock TM (2002) Regulation of microvascular permeability by vascular endothelial growth factors. J Anat 200: 581-597.
3. Silha JV, Krsek M, Sucharda P, Murphy LJ (2005) Angiogenic factors are elevated in overweight and obese individuals. Int J Obes (Lond) 29: 1308-1314.
4. Natarajan R, Bai W, Lanting L, Gonzales N, Nadler J (1997) Effects of high glucose on vascular endothelial growth factor expression in vascular smooth muscle cells. Am J Physiol 273: H2224-H2231.
5. Sone H, Kawakami Y, Okuda Y, Kondo S, Hanatani M, et al. (1996) Vascular endothelial growth factor is induced by long-term high glucose concentration and up-regulated by acute glucose deprivation in cultured bovine retinal pigmented epithelial cells. Biochem Biophys Res Commun 221: 193-198.
6. Arany Z, Foo SY, Ma Y, Ruas JL, Bommi-Reddy A, Girnun G, Cooper M, Laznik D, Chinsomboon J, Rangwala SM, Baek KH, Rosenzweig A, Spiegelman BM (2008) HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1alpha. Nature 451: 1008-1012.
7. Oltmanns KM, Gehring H, Rudolf S, Schultes B, Hackenberg C, Schweiger U, Born J, Fehm HL, Peters A (2006) Acute hypoxia decreases plasma VEGF concentration in healthy humans. Am J Physiol Endocrinol Metab 290: E434-E439.
8. Merl V, Peters A, Oltmanns KM, Kern W, Hubold C, et al. (2005) Antecedent hypoglycaemia attenuates vascular endothelial growth factor response to subsequent hypoglycaemia in healthy men. Diabet Med 22: 1278-1281.
9. Dantz D, Bewersdorf J, Fruehwald-Schultes B, Kern W, Jelkmann W, et al. (2002) Vascular endothelial growth factor: a novel endocrine defensive response to hypoglycemia. J Clin Endocrinol Metab 87: 835-840.
10. Cao Y (2007) Angiogenesis modulates adipogenesis and obesity. J Clin Invest 117: 2362-2368.
11. Mick GJ, Wang X, McCormick K (2002) White adipocyte vascular endothelial growth factor: regulation by insulin. Endocrinology 143: 948-953.
12. Miyazawa-Hoshimoto S, Takahashi K, Bujo H, Hashimoto N, et al. (2003) Elevated serum vascular endothelial growth factor is associated with visceral fat accumulation in human obese subjects. Diabetologia 46: 1483-1488.
13. Gagne D, Rivard M, Page M, Shazand K, Hugo P, et al. (2003) Blood leukocyte subsets are modulated in patients with endometriosis. Fertil Steril 80: 43-53.
14. de la Torre NG, Rubio MA, Bordiu E, Cabrerizo L, Aparicio E, et al. (2008) Effects of weight loss after bariatric surgery for morbid obesity on vascular endothelial growth factor-A, adipocytokines, and insulin. J Clin Endocrinol Metab.
15. Wada H, Satoh N, Kitaoka S, Ono K, Morimoto T, et al. (2009) Soluble VEGF receptor-2 is increased in sera of subjects with metabolic syndrome in association with insulin resistance. Atherosclerosis.
16. Sandhofer A, Tatarczyk T, Kirchmair R, Iglseder B, Paulweber B, et al. (2009) Are plasma VEGF and its soluble receptor sFlt-1 atherogenic risk factors? Crosssectional data from the SAPHIR study. Atherosclerosis.
17. Kimura K, Hashiguchi T, Deguchi T, Horinouchi S, Uto T, et al. (2007) Serum VEGF-as a prognostic factor of atherosclerosis. Atherosclerosis 194: 182-188.
18. Nammi S, Koka S, Chinnala KM, Boini KM (2004) Obesity: an overview on its current perspectives and treatment options. Nutr J 3: 3.
19. Anderwald C, Pfeiler G, Nowotny P, Anderwald-Stadler M, Krebs M, et al. (2008) Glucose turnover and intima media thickness of internal carotid artery in type 2 diabetes offspring. Eur J Clin Invest 38: 227-237.
20. DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237: E214-E223.
21. Toft I, Bonaa KH, Jenssen T (1998) Insulin resistance in hypertension is associated with body fat rather than blood pressure. Hypertension 32: 115-122.
22. Lutgendorf SK, Cole S, Costanzo E, Bradley S, Coffin J, et al. (2003) Stressrelated mediators stimulate vascular endothelial growth factor secretion by two ovarian cancer cell lines. Clin Cancer Res 9: 4514-4521.
23. Asano A, Morimatsu M, Nikami H, Yoshida T, Saito M (1997) Adrenergic activation of vascular endothelial growth factor mRNA expression in rat brown adipose tissue: implication in cold-induced angiogenesis. Biochem J 328 (Pt 1): 179-183.
24. Fredriksson JM, Lindquist JM, Bronnikov GE, Nedergaard J (2000) Norepinephrine induces vascular endothelial growth factor gene expression in brown adipocytes through a beta -adrenoreceptor/cAMP/protein kinase A pathway involving Src but independently of Erk1/2. J Biol Chem 275: 13802-13811.
25. Gunsilius E, Petzer AL, Gastl GA (2002) Blood levels of vascular endothelial growth factor in obstructive sleep apnea-hypopnea syndrome. Blood 99: 393-394.
26. Randeva HS, Lewandowski KC, Komorowski J, Murray RD, O'Callaghan CJ, et al. (2004) Growth hormone replacement decreases plasma levels of matrix metalloproteinases (2 and 9) and vascular endothelial growth factor in growth hormone-deficient individuals. Circulation 109: 2405-2410.
27. Esteghamati A, Khalilzadeh O, Anvari M, Ahadi MS, Abbasi M, et al. (2008) Metabolic syndrome and insulin resistance significantly correlate with body mass index. Arch Med Res 39: 803-808.
28. Kakizawa H, Itoh M, Itoh Y, Imamura S, Ishiwata Y, et al. (2004) The relationship between glycemic control and plasma vascular endothelial growth factor and endothelin-1 concentration in diabetic patients. Metabolism 53: 550-555.
29. Dandona P, Aljada A, Mohanty P, Ghanim H, Bandyopadhyay A, et al. (2003) Insulin suppresses plasma concentration of vascular endothelial growth factor and matrix metalloproteinase-9. Diabetes Care 26: 3310-3314.
30. Gaillard I, Keramidas M, Liakos P, Vilgrain I, Feige JJ, et al. (2000) ACTHregulated expression of vascular endothelial growth factor in the adult bovine adrenal cortex: a possible role in the maintenance of the microvasculature. J Cell Physiol 185: 226-234.
31. Yang EV, Sood AK, Chen M, Li Y, Eubank TD, et al. (2006) Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells. Cancer Res 66: 10357-10364.
32. Eriksson JW, Smith U, Waagstein F, Wysocki M, Jansson PA (1999) Glucose turnover and adipose tissue lipolysis are insulin-resistant in healthy relatives of type 2 diabetes patients: is cellular insulin resistance a secondary phenomenon? Diabetes 48: 1572-1578.